180 related articles for article (PubMed ID: 34796992)
21. Fabry disease: enzyme replacement therapy.
Bongiorno MR; Pistone G; Aricò M
J Eur Acad Dermatol Venereol; 2003 Nov; 17(6):676-9. PubMed ID: 14761135
[TBL] [Abstract][Full Text] [Related]
22. Enzyme replacement therapy in two Japanese siblings with Fabry disease, and its effectiveness on angiokeratoma and neuropathic pain.
Furujo M; Kubo T; Kobayashi M; Ohashi T
Mol Genet Metab; 2013 Nov; 110(3):405-10. PubMed ID: 23906479
[TBL] [Abstract][Full Text] [Related]
23. [The neurological manifestations of Fabry disease. A review].
Firsov KV; Kotov AS
Zh Nevrol Psikhiatr Im S S Korsakova; 2016; 116(9):98-105. PubMed ID: 27735906
[TBL] [Abstract][Full Text] [Related]
24. Fabry disease: renal involvement limited to podocyte pathology and proteinuria in a septuagenarian cardiac variant. Pathologic and therapeutic implications.
Meehan SM; Junsanto T; Rydel JJ; Desnick RJ
Am J Kidney Dis; 2004 Jan; 43(1):164-71. PubMed ID: 14712441
[TBL] [Abstract][Full Text] [Related]
25. Efficacy and safety of enzyme-replacement-therapy with agalsidase alfa in 36 treatment-naïve Fabry disease patients.
Tsuboi K; Yamamoto H
BMC Pharmacol Toxicol; 2017 Jun; 18(1):43. PubMed ID: 28592315
[TBL] [Abstract][Full Text] [Related]
26. A possible case of carbamazepine-induced renal phospholipidosis mimicking Fabry disease.
Chen J; Bai L; He Y
Clin Exp Nephrol; 2022 Mar; 26(3):303-304. PubMed ID: 35059891
[TBL] [Abstract][Full Text] [Related]
27. Fabry disease: molecular genetics of the inherited nephropathy.
Desnick RJ; Astrin KH; Bishop DF
Adv Nephrol Necker Hosp; 1989; 18():113-27. PubMed ID: 2564247
[TBL] [Abstract][Full Text] [Related]
28. Chronic kidney disease and an uncertain diagnosis of Fabry disease: approach to a correct diagnosis.
van der Tol L; Svarstad E; Ortiz A; Tøndel C; Oliveira JP; Vogt L; Waldek S; Hughes DA; Lachmann RH; Terryn W; Hollak CE; Florquin S; van den Bergh Weerman MA; Wanner C; West ML; Biegstraaten M; Linthorst GE
Mol Genet Metab; 2015 Feb; 114(2):242-7. PubMed ID: 25187469
[TBL] [Abstract][Full Text] [Related]
29. Preliminary Screening Results of Fabry Disease in Kidney Transplantation Patients: A Single-Center Study.
Yılmaz M; Uçar SK; Aşçı G; Canda E; Tan FA; Hoşcoşkun C; Çoker M; Töz H
Transplant Proc; 2017 Apr; 49(3):420-424. PubMed ID: 28340804
[TBL] [Abstract][Full Text] [Related]
30. Fabry disease.
Tarabuso AL
Skinmed; 2011; 9(3):173-7. PubMed ID: 21675497
[TBL] [Abstract][Full Text] [Related]
31. Precision medicine in Fabry disease.
Lenders M; Brand E
Nephrol Dial Transplant; 2021 Jun; 36(Suppl 2):14-23. PubMed ID: 34153986
[TBL] [Abstract][Full Text] [Related]
32. De novo mutation in a male patient with Fabry disease: a case report.
Iemolo F; Pizzo F; Albeggiani G; Zizzo C; Colomba P; Scalia S; Bartolotta C; Duro G
BMC Res Notes; 2014 Jan; 7():11. PubMed ID: 24398019
[TBL] [Abstract][Full Text] [Related]
33. The coincidence of IgA nephropathy and Fabry disease.
Maixnerová D; Tesař V; Ryšavá R; Reiterová J; Poupětová H; Dvořáková L; Goláň L; Neprašová M; Kidorová J; Merta M; Honsová E
BMC Nephrol; 2013 Jan; 14():6. PubMed ID: 23305247
[TBL] [Abstract][Full Text] [Related]
34. Impact of kidney biopsy on deciding when to initiate enzyme replacement therapy in children with Fabry disease.
Avarappattu J; Gaspert A; Spartà G; Rohrbach M
Pediatr Nephrol; 2024 Jan; 39(1):131-140. PubMed ID: 37470867
[TBL] [Abstract][Full Text] [Related]
35. Globotriaosylsphingosine accumulation and not alpha-galactosidase-A deficiency causes endothelial dysfunction in Fabry disease.
Namdar M; Gebhard C; Studiger R; Shi Y; Mocharla P; Schmied C; Brugada P; Lüscher TF; Camici GG
PLoS One; 2012; 7(4):e36373. PubMed ID: 22558451
[TBL] [Abstract][Full Text] [Related]
36. Anderson-Fabry disease in Austria.
Lorenz M; Hauser AC; Püspök-Schwarz M; Kotanko P; Arias I; Zodl H; Kramar R; Paschke E; Voigtländer T; Sunder-Plassmann G
Wien Klin Wochenschr; 2003 Apr; 115(7-8):235-40. PubMed ID: 12778775
[TBL] [Abstract][Full Text] [Related]
37. Quantification of sweat gland innervation in patients with Fabry disease: A case-control study.
Kokotis P; Üçeyler N; Werner C; Tsivgoulis G; Papanikola N; Katsanos AH; Karandreas N; Sommer C
J Neurol Sci; 2018 Jul; 390():135-138. PubMed ID: 29801874
[TBL] [Abstract][Full Text] [Related]
38. Higher rate of rheumatic manifestations and delay in diagnosis in Brazilian Fabry disease patients.
Rosa Neto NS; Bento JCB; Pereira RMR
Adv Rheumatol; 2020 Jan; 60(1):7. PubMed ID: 31907047
[TBL] [Abstract][Full Text] [Related]
39. Fabry disease: diagnostic methods in nephrology practice.
Vujkovac B
Clin Nephrol; 2017 Supplement 1; 88(13):44-47. PubMed ID: 28601129
[TBL] [Abstract][Full Text] [Related]
40. A classic variant of Fabry disease in a family with the M296I late-onset variant.
Hirashio S; Kagawa R; Tajima G; Masaki T
CEN Case Rep; 2021 Feb; 10(1):106-110. PubMed ID: 32902816
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]